Our Pipeline

Our Research & Develop process combines our cutting-edge, patented technology with nanotechnology drug delivery systems with the goal of providing first-in-class curative cancer treatments.

POP = Proof of Principal in Cancer Cells // POC = Proof of Concept in Animal Model

Current Targets

Breast Cancer


PRDM 14 Current Status POP in T-DDS Next Phase Do Animal Models POC

Lung Cancer


PRDM 2 Current Status In Vitro POP Next Phase Test T-DDS In Vitro / Do POC

Colon Cancer


PRDM 1 Current Status In Vitro POP Next Phase Test T-DDS In Vitro / Do POC

Myeloma


PRDM 1 Current Status In Vitro POP Next Phase Test T-DDS In Vitro / Do POC

Leukemia


PRDM 16 Current Status Identified Next Phase In Vitro POP

Prostate Cancer


PRDM 2 Current Status Identified Next Phase In Vitro POP

Liver Cancer


PRDM 2 Current Status Identified Next Phase In Vitro POP

Lymphoma


PRDM 1 Current Status Identified Next Phase In Vitro POP